Mizuho Securities lifted the Intel stock price target to $135 from $128 on Sunday, June 21, and kept a Neutral rating. The new level implies just 0.75% upside from Intel's current price of $133.99. For holders, that is a modest move in valuation, not a call for a breakaway rerating.
Vijay Rakesh’s 10–15% view
Vijay Rakesh tied the change to EMIB-T and Foveros, saying those advanced packaging technologies could help Intel capture 10–15% of the advanced packaging market in the long term. He also linked the revision to Intel's announcement that it would work with Apple to design and manufacture chips in the U.S.
5.5% is the size of Mizuho's target increase, from $128 to $135, and it keeps the rating at Neutral. That combination matters because it raises the valuation bar without changing the analyst's stance on the shares.
Bernstein’s $100 target
$100 was the price target Stacy Rasgon at Bernstein assigned on June 17, and it pointed to roughly 15% downside from the latest closing price at the time. Over the past three months, 25 analysts have rated Intel a Buy, while 11 analysts have given Intel a Buy rating, showing how mixed the Street's signals remain around the name.
$92.75 was the average Intel share price target for the next 12 months, which implied roughly 30% downside from current levels. That puts Mizuho's $135 target above both Bernstein's $100 view and the broader average, yet still only fractionally above where Intel traded at $133.99.
Intel in the Wall Street split
Intel now sits between a higher single-firm target and a much lower consensus target, with the gap centered on how quickly packaging execution and the Apple-related U.S. chip work can translate into cash flow. If those efforts progress, the valuation gap can narrow; if they stall, the current share price leaves little room for error.
